IFNA1 and COVID-19: This study aimed to determine the prevalence of anti-IFN-α AAbs in unvaccinated hospitalized COVID-19 patients and investigate their relationship with disease severity, as measured by the World Health Organization (WHO) clinical management of COVID-19 guidelines [10].